3,092
Views
1
CrossRef citations to date
0
Altmetric
Review articles

The cost-effectiveness of sexual and reproductive health and rights interventions in low- and middle-income countries: a scoping review

, ORCID Icon, & ORCID Icon

References

  • Starrs A, Barker G, Basu A, et al. Accelerate progress – sexual and reproductive health and rights for all: report of the Guttmacher– Lancet commission. Lancet. 2018;391:2642–2692.
  • Every Woman Every Child. The global strategy for women’s, children’s, and adolescents’ health (2016-2030). New York; 2016. https://www.who.int/life-course/partners/global-strategy/ewec-globalstrategyreport-200915.pdf?ua=1.
  • UNFPA. Sexual and reproductive health and rights: an essential element of Universal Health Coverage. 2019.
  • World Health Organization. Together on the road to universal health coverage. Geneva: A Call to Action; 2017; https://apps.who.int/iris/bitstream/handle/10665/258962/WHO-HIS-HGF-17.1-eng.pdf?sequence=1.
  • World Health Organization. Making fair choices on the path to universal health coverage. Final report of the WHO Consultative Group on Equity and Universal Health Coverage. Geneva; 2014 https://apps.who.int/iris/bitstream/handle/10665/112671/9789241507158_eng.pdf?sequence=1.
  • World Health Organization. Health financing for universal coverage. Efficiency and universal coverage. 2020.
  • Glassman A, Giedion U, Smith P. What’s in, what’s out: designing benefits for universal health coverage. Washington, DC: Center for Global Development; 2017.
  • Sen G, Govender V. Sexual and reproductive health and rights in changing health systems. Glob Public Health. 2015;10:228–242.
  • Peters M, Godfrey C, McInerney P, et al. Chapter 11: scoping reviews (2020 version). In: Aromataris E, Munn Z, editors. Joanna Briggs Institute reviewer’s manual. JBI; 2020. https://reviewersmanual.joannabriggs.org/
  • Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.
  • Khalil H, Peters M, Godfrey CM, et al. An evidence-based approach to scoping reviews. Worldviews Evidence-Based Nurs. 2016;13:118–123.
  • Tricco A, Lillie E, Zarin W, et al. PRISMA extension for Scoping Reviews (PRISMAScR): checklist and explanation. Ann Intern Med. 2018;169:467–473.
  • Colquhoun HL, Levac D, O’Brien KK, et al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol. 2014;67:1291–1294.
  • McGowan J, Sampson M, Salzwedel D. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–46.
  • Stenberg K, Hanssen O, Edejer TT-T, et al. Financing transformative health systems towards achievement of the health Sustainable development goals: a model for projected resource needs in 67 low-income and middle-income countries. Lancet Glob Heal. 2017;5:e875–e887.
  • Drummond M, Sculpher M, Torrance G, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press Inc; 2005.
  • Shillcutt SD, Walker DG, Goodman CA, et al. Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics. 2009;27:903–917.
  • Birch S, Gafni A. Information created to evade reality (ICER): things we should not look to for answers. Pharmacoeconomics. 2006;24:1121–1131.
  • Evans DB, Lim SS, Adam T, et al. Evaluation of current strategies and future priorities for improving health in developing countries. Br Med J. 2005;331:1457–1461.
  • Watkins DA, Jamison DT, Mills T, et al. Universal Health Coverage and Essential Packages of Care. In: Jamison DT, Gelband H, Horton S et al., editors. Disease control priorities: improving health and reducing poverty, 3rd ed. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2017.
  • Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Br Med J. 2013;346:f1049–f1049. DOI:https://doi.org/10.1136/bmj.f1049
  • Yamin AE, Boulanger VM. Embedding sexual and reproductive health and rights in a transformational development framework: lessons learned from the MDG targets and indicators. Reprod Health Matters. 2013;21:74–85.
  • Packard RM. A history of global health: interventions into the lives of other peoples. Baltimore (MD): Johns Hopkins University Press; 2016.
  • Clark J. Medicalization of global health 1: has the global health agenda become too medicalized? Glob Health Action. 2014;7:23998.
  • Clark J. Medicalization of global health 4: the universal health coverage campaign and the medicalization of global health. Glob Health Action. 2014;7:24004.
  • Remme M, Siapka M, Vassall A, et al. The cost and cost-effectiveness of gender-responsive interventions for HIV: a systematic review. J Int AIDS Soc. 2014;17:19228.
  • Church K, Gassner J, Elliott M. Exporting bad policy: an introduction to the special issue on the GGR’s impact. Sex Reprod Heal Matters. 2020;28:1–4.
  • Cousins S. COVID-19 has “devastating” effect on women and girls. Lancet. 2020;396:301–302.
  • Verguet S, Kim JJ, Jamison DT. Extended cost-effectiveness analysis for health policy assessment: A tutorial. Pharmacoeconomics. 2016;34:913–923.
  • Cookson R, Mirelman AJ, Griffin S, et al. Using cost-effectiveness analysis to address health equity concerns. Value Heal J Int Soc Pharmacoeconomics Outcomes Res. 2017;20:206–212.
  • Baeten S, Baltussen R, Uyl-de Groot C, et al. Incorporating equity–efficiency interactions in cost-effectiveness analysis – three approaches applied to breast cancer control. Value Heal. 2010;13:573–579.